The law broadens the ability of law enforcement agencies to use rapid DNA sequencing technology and upload resulting data into a federal database.
The Seattle-based firm plans to partner with pharma and biotech to use its duplex sequencing technology in applications such as oncology and forensics.
The researchers plan to commercialize the method, which they said can have applications in both forensics and oncology.
SmallPond is part of a broader collaboration to provide services to the Bermuda police department and to establish a national database of DNA profiles.
Thermo Fisher Scientific has developed forensics panels to run on its S5 sequencing system in anticipation that the forensics market will slowly move from CE to NGS.
New York Genome Center-led researchers have found that short tandem repeats may regulate gene expression rather than representing neutral variation.
The new platform is smaller and less expensive than the company's first-generation forensic DNA platform, processing a single DNA sample in around 70 minutes.
OCME's Department of Forensic Biology recently started testing next-generation sequencing for forensic applications.
Vallone recently authored a review of the field, noting that fully integrated rapid systems have special advantages.
In Genome Research this week: methylation patterns in multiple myeloma, recent Y chromosome bottleneck, and more.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.